DiaSorin S.p.A. provided earnings guidance for the second half of 2020. The company expects at the light of the good performance achieved in first half of 2020 and taking into account the importance of the diagnostic industry in managing the consequences of the COVID pandemic, the management is not expecting a negative impact on the results of the second half of the year.